The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer.

Authors:

Dearnaley, David P, Saltzstein, Daniel R, Sylvester, John E, Karsh, Lawrence, Mehlhaff, Bryan A, Pieczonka, Christopher, Bailen, James L, Shi, Hongliang, Ye, Zhan, Faessel, Hélène M, Lin, Huamao, Zhu, Yanyan, Saad, Fred, MacLean, David B, Shore, Neal D,

Journal

European urology

Year

2020

Volume

Apr 6

Physicians